Stephen Michael Kelsey
CIK: 0001462808
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Revolution Medicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (39 total)
- Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct85 shares at avg. $195.01$17K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.5K shares at avg. $199.30$1.1M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct5K shares at avg. $204.84$1.0M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct17.9K shares at avg. $203.87$3.7M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct18.9K shares at avg. $203.06$3.8M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct21.4K shares at avg. $201.75$4.3M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct13.4K shares at avg. $200.78$2.7M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct11.8K shares at avg. $200.11$2.4M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct800 shares at avg. $198.55$159K - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct52.5K shares at avg. $42.45$2.2M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct40K shares at avg. $40.74$1.6M - Sep 11, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.3K shares at avg. $205.81$673K - Jun 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct4.2K shares at avg. $156.12$652K - Mar 17, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct4.3K shares at avg. $99.48$428K - Mar 1, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct21.1K shares- - Dec 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.4K shares at avg. $76.82$418K - Oct 13, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct25K shares at avg. $4.73$118K - Oct 13, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct25K shares at avg. $48.54$1.2M - Sep 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.4K shares at avg. $45.82$246K - Sep 15, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.3K shares at avg. $46.93$62K - Sep 15, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct25K shares at avg. $4.73$118K - Sep 15, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct23.7K shares at avg. $45.92$1.1M - Sep 11, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct55.9K shares at avg. $44.48$2.5M - Sep 11, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct100K shares at avg. $4.73$473K - Sep 11, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct44.1K shares at avg. $43.58$1.9M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 85 | $195.01 | $16,576 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,484 | $199.30 | $1,092,979 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,995 | $204.84 | $1,023,189 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 17,949 | $203.87 | $3,659,309 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 18,869 | $203.06 | $3,831,550 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 21,447 | $201.75 | $4,326,947 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 13,368 | $200.78 | $2,683,986 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 11,833 | $200.11 | $2,367,955 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 800 | $198.55 | $158,840 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 52,500 | $42.45 | $2,228,625 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 40,031 | $40.74 | $1,630,863 | Direct |
| Sep 11, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,270 | $205.81 | $672,991 | Direct |
| Jun 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,175 | $156.12 | $651,798 | Direct |
| Mar 17, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,302 | $99.48 | $427,965 | Direct |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | Award(A) | 21,100 | - | $0 | Direct |
| Dec 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,447 | $76.82 | $418,423 | Direct |
| Oct 13, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 25,000 | $4.73 | $118,250 | Direct |
| Oct 13, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 25,000 | $48.54 | $1,213,540 | Direct |
| Sep 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,367 | $45.82 | $245,942 | Direct |
| Sep 15, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,318 | $46.93 | $61,854 | Direct |
| Sep 15, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 25,000 | $4.73 | $118,250 | Direct |
| Sep 15, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 23,682 | $45.92 | $1,087,418 | Direct |
| Sep 11, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 55,941 | $44.48 | $2,488,519 | Direct |
| Sep 11, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 100,000 | $4.73 | $473,000 | Direct |
| Sep 11, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 44,059 | $43.58 | $1,919,963 | Direct |
1-25 of 39 transactions
About Kelsey Stephen Michael
Kelsey Stephen Michael (SEC CIK 0001462808) files insider reports with the SEC as Officer of Revolution Medicines, Inc. (RVMD).
Signal8 holds 17 ownership filings by Kelsey Stephen Michael, all Form 4s, filed between Sep 16, 2024 and Sep 18, 2026. Those filings report 39 transactions, from Sep 13, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kelsey Stephen Michael's filings is in REDWOOD CITY, CA.
Recent filings by Kelsey Stephen Michael
- Sep 16, 2026: Open-market sales of RVMD shares (2 lines, Form 4, code S).
- Sep 11, 2026: Open-market sales of RVMD shares (7 lines, Form 4, code S).
- Sep 11, 2026: Option exercises of RVMD shares (2 lines, Form 4, code M).
- Sep 11, 2026: Open-market sale of RVMD shares (Form 4, code S).
- Jun 16, 2026: Open-market sale of RVMD shares (Form 4, code S).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Horn Margaret A, Chief Operating Officer
- GOLDSMITH MARK A